{"id":12,"date":"2024-05-13T11:22:22","date_gmt":"2024-05-13T11:22:22","guid":{"rendered":"https:\/\/demosites.io\/marketing-agency-gb\/?p=12"},"modified":"2026-01-04T22:18:26","modified_gmt":"2026-01-04T22:18:26","slug":"the-future-of-marketing-automation","status":"publish","type":"post","link":"https:\/\/www.h2founders.com\/cs\/the-future-of-marketing-automation\/","title":{"rendered":"H2 Medical Technologies otev\u00edr\u00e1 investor\u016fm dve\u0159e k unik\u00e1tn\u00edmu \u0159e\u0161en\u00ed pro prevenci a l\u00e9\u010dbu Alzheimerovy demence"},"content":{"rendered":"

\u010cesk\u00e1 spole\u010dnost H2 Medical Technologies, \u010dlen skupiny H2 Global Group, p\u0159edstavila sv\u00e9 technologie a patentovanou terapii pro prevenci a podporu l\u00e9\u010dby Alzheimerovy choroby. S touto inovac\u00ed se nyn\u00ed p\u0159ipravuje na presti\u017en\u00ed konferenci LSI Europe 2025 v Lond\u00fdn\u011b, kde sv\u00e9 technologie p\u0159edvede p\u0159edn\u00edm sv\u011btov\u00fdm odborn\u00edk\u016fm v oblasti MedTech a HealthTech. Je\u0161t\u011b p\u0159ed vstupem glob\u00e1ln\u00edho partnera maj\u00ed \u010de\u0161t\u00ed investo\u0159i mimo\u0159\u00e1dnou p\u0159\u00edle\u017eitost st\u00e1t se sou\u010d\u00e1st\u00ed tohoto pr\u016flomov\u00e9ho projektu.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

P\u0159edstavte si, \u017ee jste u zrodu objevu, kter\u00fd m\u00e1 \u0161anci zm\u011bnit \u017eivoty milion\u016f lid\u00ed po cel\u00e9m sv\u011bt\u011b \u2013 a to v\u0161e poch\u00e1z\u00ed z \u010cesk\u00e9 republiky, zem\u011b, kter\u00e1 dala sv\u011btu g\u00e9nia antivirotik prof. Anton\u00edna Hol\u00e9ho, vizion\u00e1\u0159sk\u00e9ho podnikatele Tom\u00e1\u0161e Ba\u0165u, vyn\u00e1lezce kontaktn\u00edch \u010do\u010dek prof. Otto Wichterleho a otce polarografie Jaroslava Heyrovsk\u00e9ho.<\/p>\n\n\n\n

\u010cesk\u00e1 inova\u010dn\u00ed stopa pokra\u010duje v Ostrav\u011b \u2013 spole\u010dnost H2 Medical Technologies, \u010dlen skupiny H2 Global Group, vyvinula prvn\u00ed za\u0159\u00edzen\u00ed na sv\u011bt\u011b vyu\u017e\u00edvaj\u00edc\u00ed molekul\u00e1rn\u00ed vod\u00edk pro prevenci a podporu l\u00e9\u010dby Alzheimerovy choroby.<\/p>\n\n\n\n

Unik\u00e1tn\u00ed uzn\u00e1n\u00ed na sv\u011btov\u00e9 sc\u00e9n\u011b<\/h3>\n\n\n\n

V z\u00e1\u0159\u00ed tohoto roku vystoup\u00ed zakladatel a CEO spole\u010dnosti David Mar\u0161\u00e1lek na LSI Europe Summit 2025 v Lond\u00fdn\u011b \u2013 jedn\u00e9 z nejpresti\u017en\u011bj\u0161\u00edch sv\u011btov\u00fdch konferenc\u00ed pro investory a inov\u00e1tory v medic\u00edn\u011b a technologi\u00edch. H2 Global Group bude jedin\u00fdm \u010desk\u00fdm z\u00e1stupcem v sektoru MedTech a HealthTech, kter\u00fd stovk\u00e1m investor\u016f a l\u00eddr\u016f sv\u011btov\u00e9 medic\u00edny p\u0159edstav\u00ed nejen nov\u00fd prototyp za\u0159\u00edzen\u00ed vyvinut\u00fd pro klinick\u00e9 studie, jejich\u017e c\u00edlem je registrace prvn\u00edho vod\u00edkov\u00e9ho zdravotnick\u00e9ho prost\u0159edku na sv\u011bt\u011b, ale i kompletn\u00ed vod\u00edkov\u00e9 \u0159e\u0161en\u00ed.<\/p>\n\n\n\n

Sv\u011btov\u00e9 know-how z Japonska<\/h3>\n\n\n\n

Projekt stoj\u00ed na v\u00edce ne\u017e 30 letech v\u011bdeck\u00e9ho v\u00fdzkumu, registrovan\u00fdch patentech a spolupr\u00e1ci s japonsk\u00fdm v\u011bdeck\u00fdm t\u00fdmem pod veden\u00edm sv\u011btov\u011b uzn\u00e1van\u00e9ho profesora Shigeo Ohty, kter\u00fd je z\u00e1rove\u0148 spole\u010dn\u00edkem v H2 Global Group.<\/p>\n\n\n\n

\u201eVod\u00edku se v\u011bnuji od roku 2011, vyv\u00edj\u00edm nov\u00e1 \u0159e\u0161en\u00ed ve form\u011b produkt\u016f a za\u0159\u00edzen\u00ed a registruji patenty a u\u017eitn\u00e9 vzory pro praktick\u00e9 vyu\u017eit\u00ed vod\u00edku v r\u016fzn\u00fdch oblastech zdravotnictv\u00ed. Posledn\u00ed t\u0159i roky jsme s t\u00fdmem intenzivn\u011b pracovali na tom, abychom pomohli lidem zejm\u00e9na v oblasti neurodegenerativn\u00edch onemocn\u011bn\u00ed,\u201c \u0159\u00edk\u00e1 David Mar\u0161\u00e1lek.<\/p>\n\n\n\n

\u201eV\u00edm, jak n\u00e1ro\u010dn\u00e9 je pro jednotlivce i cel\u00e9 rodiny pe\u010dovat o \u010dlov\u011bka s demenc\u00ed nebo Alzheimerovou chorobou \u2013 sledovat, jak postupn\u011b ztr\u00e1c\u00ed vzpom\u00ednky, orientaci a nakonec i schopnost se o sebe postarat. Je to obrovsk\u00e1 z\u00e1t\u011b\u017e nejen pro bl\u00edzk\u00e9, ale i pro st\u00e1t a syst\u00e9m. Podle dat WHO dnes s demenc\u00ed bojuje p\u0159es 50 milion\u016f lid\u00ed a do roku 2050 by to mohlo b\u00fdt v\u00edce ne\u017e 154 milion\u016f lid\u00ed po cel\u00e9m sv\u011bt\u011b; proto je prevence a investice do n\u00ed tak z\u00e1sadn\u00ed. Chceme lidem d\u00e1t do rukou efektivn\u00ed n\u00e1stroj, kter\u00fd pom\u016f\u017ee chr\u00e1nit jejich vzpom\u00ednky, vztahy a nez\u00e1vislost.\u201c<\/p>\n\n\n\n

Tato technologie podle Davida Mar\u0161\u00e1lka c\u00edl\u00ed nejen na Alzheimerovu chorobu, ale i na regeneraci nervov\u00e9 soustavy, prevenci st\u00e1rnut\u00ed mozku a dal\u0161\u00ed neurologick\u00e9 oblasti. \u201eC\u00edl je jasn\u00fd: dostat toto na\u0161e unik\u00e1tn\u00ed \u0159e\u0161en\u00ed do standardn\u00edho syst\u00e9mu \u00fahrad zdravotn\u00ed p\u00e9\u010de, a t\u00edm ho zp\u0159\u00edstupnit co nejv\u011bt\u0161\u00edmu po\u010dtu lid\u00ed.\u201c<\/p>\n\n\n\n

Od l\u00e1zn\u00ed a\u017e po veterin\u00e1rn\u00ed p\u00e9\u010di<\/h3>\n\n\n\n

Vedle p\u0159\u00edstroj\u016f p\u0159ipravovan\u00fdch pro medic\u00ednskou certifikaci spole\u010dnost pod veden\u00edm PharmDr. Milana Kraj\u00ed\u010dka a prof. Ohty vyvinula a vyr\u00e1b\u00ed balenou vod\u00edkem sycenou vodu H2 Premium Water a dopl\u0148ky stravy, jako je H2 Brain \u2013 unik\u00e1tn\u00ed dvouf\u00e1zov\u00e9 tablety pro zv\u00fd\u0161en\u00ed p\u0159irozen\u00e9 produkce molekul\u00e1rn\u00edho vod\u00edku st\u0159evn\u00edm mikrobiomem a podporu spr\u00e1vn\u00e9 funkce mozku.<\/p>\n\n\n\n

H2 Medical Technologies je nav\u00edc jedinou spole\u010dnost\u00ed na sv\u011bt\u011b, kter\u00e1 m\u00e1 ofici\u00e1ln\u00ed schv\u00e1len\u00ed pro pou\u017eit\u00ed sv\u00fdch p\u0159\u00edstroj\u016f ve veterin\u00e1rn\u00ed medic\u00edn\u011b od \u00dastavu pro st\u00e1tn\u00ed kontrolu veterin\u00e1rn\u00edch bioprepar\u00e1t\u016f a l\u00e9\u010div (\u00daSKVBL). Na trh brzy p\u0159ijdou i speci\u00e1ln\u00ed produkty pro p\u00e9\u010di o ko\u010dky, psy a kon\u011b. Vod\u00edkov\u00e1 \u0159e\u0161en\u00ed H2 Global Group vyu\u017e\u00edv\u00e1 ji\u017e n\u011bkolik let \u0159ada tuzemsk\u00fdch i zahrani\u010dn\u00edch l\u00e9\u010debn\u00fdch l\u00e1zn\u00ed, l\u00e1ze\u0148sk\u00fdch dom\u016f, regenera\u010dn\u00edch center, stomatologick\u00fdch klinik i sportovn\u00edch klub\u016f.<\/p>\n\n\n\n

Neopakovateln\u00e1 investi\u010dn\u00ed p\u0159\u00edle\u017eitost<\/h3>\n\n\n\n

Mo\u017enost investovat do t\u00e9to \u010desk\u00e9 technologick\u00e9 revoluce je st\u00e1le otev\u0159en\u00e1 pro \u010desk\u00e9 investory. Doposud byl projekt financov\u00e1n \u010desk\u00fdmi investory p\u0159edev\u0161\u00edm prost\u0159ednictv\u00edm dluhopis\u016f. V zahrani\u010d\u00ed je b\u011b\u017en\u00e9, \u017ee lid\u00e9 vstupuj\u00ed do podobn\u00fdch MedTech projekt\u016f v ran\u00e9 f\u00e1zi, z\u00edsk\u00e1vaj\u00ed pod\u00edl (equity) a p\u0159i \u00fasp\u011b\u0161n\u00e9m exitu svou hodnotu n\u00e1sobn\u011b zhodnot\u00ed. V \u010cesk\u00e9 republice je pov\u011bdom\u00ed o takov\u00fdch mo\u017enostech st\u00e1le n\u00edzk\u00e9 \u2013 o to v\u011bt\u0161\u00ed je \u0161ance b\u00fdt u toho v dob\u011b, kdy m\u00e1 projekt nejv\u011bt\u0161\u00ed r\u016fstov\u00fd potenci\u00e1l.<\/p>\n\n\n\n

\u201eJsme p\u0159esv\u011bd\u010deni, \u017ee kombinace v\u011bdeck\u00fdch d\u016fkaz\u016f, patentov\u00e9 ochrany, mezin\u00e1rodn\u00ed spolupr\u00e1ce a zku\u0161en\u00e9ho t\u00fdmu n\u00e1m umo\u017en\u00ed st\u00e1t se sv\u011btov\u00fdm l\u00eddrem ve vod\u00edkov\u00fdch technologi\u00edch pro zdravotnictv\u00ed,\u201c dod\u00e1v\u00e1 Mar\u0161\u00e1lek. \u201eTakov\u00e9 \u0161ance nep\u0159ich\u00e1zej\u00ed \u010dasto \u2013 a a\u017e se o n\u00e1s bude ps\u00e1t v u\u010debnic\u00edch, m\u016f\u017eete \u0159\u00edct: Byl jsem u toho. Jsem sou\u010d\u00e1st\u00ed siln\u00e9 vize spole\u010dnosti, kde je vod\u00edk molekulou \u017eivota, kter\u00e1 spojuje sv\u011bt,\u201c uzav\u00edr\u00e1 zakladatel H2 Global Group David Mar\u0161\u00e1lek.<\/p>\n\n\n\n

Zdroj: https:\/\/www.ceskenoviny.cz\/tiskove\/zpravy\/h2-medical-technologies-otevira-investorum-cestu-k-unikatnimu-reseni-pro-prevenci-a-lecbu-alzheimerovy-demence\/2708766<\/a><\/p>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

The Czech company H2 Medical Technologies, a member of the H2 Global Group, has presented its technologies and patented therapy for the prevention and treatment support of Alzheimer’s disease. With this innovation, it is now preparing for the prestigious LSI Europe 2025 conference in London, where it will showcase its technologies to leading world experts… H2 Medical Technologies otev\u00edr\u00e1 investor\u016fm dve\u0159e k unik\u00e1tn\u00edmu \u0159e\u0161en\u00ed pro prevenci a l\u00e9\u010dbu Alzheimerovy demence<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":1052,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-12","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-marketing"],"_links":{"self":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts\/12","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/comments?post=12"}],"version-history":[{"count":2,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts\/12\/revisions"}],"predecessor-version":[{"id":1086,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/posts\/12\/revisions\/1086"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/media\/1052"}],"wp:attachment":[{"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/media?parent=12"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/categories?post=12"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.h2founders.com\/cs\/wp-json\/wp\/v2\/tags?post=12"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}